Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Consolidated Net Income: 2011-2025

Historic Consolidated Net Income for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to $620,000.

  • Aytu Biopharma's Consolidated Net Income rose 415.75% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 195.99%. This contributed to the annual value of $620,000 for FY2025, which is 118.65% up from last year.
  • According to the latest figures from FY2025, Aytu Biopharma's Consolidated Net Income is $620,000, which was up 118.65% from -$3.3 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Consolidated Net Income ranged from a high of $620,000 in FY2025 and a low of -$108.8 million during FY2022.
  • In the last 3 years, Aytu Biopharma's Consolidated Net Income had a median value of -$3.3 million in 2024 and averaged -$6.6 million.
  • Per our database at Business Quant, Aytu Biopharma's Consolidated Net Income slumped by 327.93% in 2021 and then skyrocketed by 118.65% in 2025.
  • Aytu Biopharma's Consolidated Net Income (Yearly) stood at -$58.3 million in 2021, then plummeted by 86.62% to -$108.8 million in 2022, then spiked by 84.21% to -$17.2 million in 2023, then soared by 80.65% to -$3.3 million in 2024, then surged by 118.65% to $620,000 in 2025.